FDA’s director of the Office of Dietary Supplement Programs (ODSP), Cara Welch, PhD, stopped by SupplySide East to present an overview of the agency’s FY23 activities related to dietary supplements and FY24 plans as well as an update on the pending Human Foods Program reorganization. She sat down with NutraIngredients-USA to discuss these topics and more.
Registration is open for the DSHEA Summit, a landmark event bringing together the architects of the law and leading industry voices, including current and former FDA officials.
As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the greatest challenge for the industry collectively is finding consensus on the issues that matter.